⌘K

Login Start Free

Home/Filings/4/0001437749-23-010666

4//SEC Filing

Woods Lori A 4

Accession 0001437749-23-010666

CIK 0000728387other

View on SEC.gov Company Profile

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 5:52 PM ET

Size

11.1 KB

Accession

0001437749-23-010666

Insider Transaction Report

Form 4

Period: 2023-04-13

Perspective Therapeutics, Inc.ISR

Director

Transactions

Exercise/Conversion
Common Stock
2023-04-13$0.61/sh+163,934$100,000→ 1,310,972 total(indirect: By Trust)
Exercise/Conversion
Stock Options (right to buy)
2023-04-17−23,566→ 0 total
Exercise: $0.61Exp: 2030-06-23→ Common Stock (0 underlying)
Exercise/Conversion
Common Stock
2023-04-17$0.61/sh+23,566$14,375→ 1,334,538 total(indirect: By Trust)
Exercise/Conversion
Stock Options (right to buy)
2023-04-13−163,934→ 0 total
Exercise: $0.61Exp: 2030-06-23→ Common Stock (23,566 underlying)

Holdings

Common Stock
48,076

Footnotes (1)

[F1]250,000 stock options were granted on 6/23/2020. 25% vested on 6/23/2020, 25% vested on 6/23/2021, 25% vested on 6/23/2022 and the remaining 25% vested on 2/3/2023.

Documents

1 file

4
rdgdoc.xmlPrimary
FORM 4

Issuer

Perspective Therapeutics, Inc.

CIK 0000728387

Entity typeother

Related Parties

1

filerCIK 0001393007

Filing Metadata

Form type: 4
Filed: Apr 18, 8:00 PM ET
Accepted: Apr 19, 5:52 PM ET
Size: 11.1 KB

View on SEC.gov